Evaxion Biotech A/S (EVAX)
NASDAQ·Healthcare·Biotechnology
$3.01
+9.06%
Mkt Cap $19.45M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$11.67
Range $9.00 – $16.00
Implied Upside
+287.7%
Consensus $11.67 vs current $3.01
NASDAQ·Healthcare·Biotechnology
$3.01
+9.06%
Mkt Cap $19.45M
No recent rating data.
Price Target (4 analysts)
$11.67
Range $9.00 – $16.00
+287.7%
Consensus $11.67 vs current $3.01